Viewing Study NCT05689151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-26 @ 4:44 PM
Study NCT ID: NCT05689151
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2023-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
None Eczema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic dermatitis View
None AD View
None Eczema View
None Abrocitinib View
None JAK inhibitors View
None France View
None Dermatitis View
None Atopic View
None Inflammatory disease View
None dermatology View